Exane BNP Paribas Initiates Coverage On Xylem with Outperform Rating, Announces Price Target of $150
Portfolio Pulse from Benzinga Newsdesk
Exane BNP Paribas analyst Andrew Buscaglia initiates coverage on Xylem (NYSE:XYL) with an Outperform rating and a price target of $150.
March 12, 2024 | 4:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Exane BNP Paribas initiated coverage on Xylem with an Outperform rating and a price target of $150.
The initiation of coverage by Exane BNP Paribas with an Outperform rating and a high price target suggests a strong bullish outlook for Xylem. This is likely to positively influence investor sentiment and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100